Zhang Y - Search Results

1

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer.

Zou Z, Liu R, Liang Y, Zhou R, Dai Q, Han Z, Jiang M, Zhuo Y, Zhang Y, Feng Y, Zhu X, Cai S, Lin J, Tang Z, Zhong W, Liang Y. Zou Z, et al. Among authors: zhang y. Front Genet. 2021 Aug 13;12:703210. doi: 10.3389/fgene.2021.703210. eCollection 2021. Front Genet. 2021. PMID: 34484299 Free PMC article.

2

Down-regulation of ACACA suppresses the malignant progression of Prostate Cancer through inhibiting mitochondrial potential.

Zhang H, Liu S, Cai Z, Dong W, Ye J, Cai Z, Han Z, Liang Y, Zhuo Y, Luo Y, Zhu X, Deng Y, Zhang Y, Liu R, Feng Y, Lai J, Zhou R, Tan H, Zhong W. Zhang H, et al. Among authors: zhang y. J Cancer. 2021 Jan 1;12(1):232-243. doi: 10.7150/jca.49560. eCollection 2021. J Cancer. 2021. PMID: 33391420 Free PMC article.

3

The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders.

Cai S, Feng Y, Ye J, Deng Y, Cai Z, Zhu X, Liu R, Zhang Y, Zou Z, Tang Z, Han Z, Hon CT, Zhong W, He H. Cai S, et al. Among authors: zhang y. Transl Androl Urol. 2021 Sep;10(9):3579-3590. doi: 10.21037/tau-21-400. Transl Androl Urol. 2021. PMID: 34733654 Free PMC article.

4

Untargeted metabolomics reveals alterations in the metabolic reprogramming of prostate cancer cells by double-stranded DNA-modified gold nanoparticles.

Zhang Y, Lin J, Zhuo Y, Zou Z, Li Y, Yang H, Xie W, Zeng J, Deng Y, Cai S, Ye J, Zou F, Zhong W. Zhang Y, et al. Biomater Adv. 2022 Apr;135:212745. doi: 10.1016/j.bioadv.2022.212745. Epub 2022 Mar 18. Biomater Adv. 2022. PMID: 35929217 Free article.

5

Ferrocene-Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis.

Lin J, Yang H, Zhang Y, Zou F, He H, Xie W, Zou Z, Liu R, Xu Q, Zhang J, Zhong G, Li Y, Tang Z, Deng Y, Cai S, Wang L, Huang Y, Zhuo Y, Jiang X, Zhong W. Lin J, et al. Among authors: zhang j, zhang y. Small. 2023 Jan;19(2):e2205024. doi: 10.1002/smll.202205024. Epub 2022 Nov 18. Small. 2023. PMID: 36398604

6

Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma.

Deng Y, Guo K, Tang Z, Feng Y, Cai S, Ye J, Xi Y, Li J, Liu R, Cai C, Tan Z, Zhang Y, Han Z, Zeng G, Zhong W. Deng Y, et al. Among authors: zhang y. Front Immunol. 2022 Nov 24;13:1046790. doi: 10.3389/fimmu.2022.1046790. eCollection 2022. Front Immunol. 2022. PMID: 36505457 Free PMC article.

7

Molecular predictors of metastasis in patients with prostate cancer.

Lin J, Zhuo Y, Zhang Y, Liu R, Zhong W. Lin J, et al. Among authors: zhang y. Expert Rev Mol Diagn. 2023 Mar;23(3):199-215. doi: 10.1080/14737159.2023.2187289. Epub 2023 Mar 8. Expert Rev Mol Diagn. 2023. PMID: 36860119 Review.

8

FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation.

Liu R, Zou Z, Chen L, Feng Y, Ye J, Deng Y, Zhu X, Zhang Y, Lin J, Cai S, Tang Z, Liang Y, Lu J, Zhuo Y, Han Z, Ling X, Liang Y, Wang Z, Zhong W. Liu R, et al. Among authors: zhang y. Cell Death Dis. 2024 Jan 17;15(1):64. doi: 10.1038/s41419-024-06450-x. Cell Death Dis. 2024. PMID: 38233415 Free PMC article.

9

A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy.

Xie W, Zhang Y, Xu Q, Zhong G, Lin J, He H, Du Q, Tan H, Chen M, Wu Z, Deng Y, Han Z, Lu J, Ye J, Zou F, Zhuo Y, Zhong W. Xie W, et al. Among authors: zhang y. Int J Nanomedicine. 2024 May 2;19:3957-3972. doi: 10.2147/IJN.S455355. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38711614 Free PMC article.

10

Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma.

Ren X, Zhang Y, Lyu Y, Jin B, Guo H, Wu J, Li X, Liu X. Ren X, et al. Among authors: zhang y. Cancer Biomark. 2019;26(2):139-150. doi: 10.3233/CBM-190201. Cancer Biomark. 2019. PMID: 31356196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259,840 results

Search Page

Filters